Bath & Body Works Inc. (NYSE: BBWI) saw its stock price plummet 6.08% in pre-market trading on Thursday, as investors anxiously await the company's third-quarter earnings report scheduled for release before the opening bell. The sharp decline reflects growing concerns about the company's performance amid challenging market conditions.

Analysts are projecting earnings per share (EPS) of $0.40 for the quarter, down from $0.49 in the same period last year. This anticipated decline in profitability, despite expectations of a slight increase in revenue to $1.63 billion from $1.61 billion a year ago, appears to be fueling investor unease. The market's reaction suggests that there may be worries about the company's ability to maintain profit margins in the face of potential cost pressures or changing consumer behavior.

Recent analyst ratings for Bath & Body Works have been mixed, reflecting the uncertainty surrounding the company's near-term prospects. While some analysts maintain optimistic outlooks, others have downgraded the stock or lowered their price targets. For instance, Raymond James recently downgraded BBWI from Outperform to Market Perform, while Wells Fargo maintained an Overweight rating but cut its price target from $44 to $33. The stock closed at $21.04 on Wednesday, and today's pre-market movement suggests that investors are positioning themselves cautiously ahead of the earnings announcement, potentially anticipating disappointing results or guidance.